483 Intersect ENT Mar 2019

483 Intersect ENT Mar 2019

Andrew Haack FDA$119.00 - Available Now

FDA investigators audited the Intersect ENT - Menlo Park, CA, United States facility and issued inspectional observations (via FDA 483) on 06 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Mar 2019
  • Location: Menlo Park, United States
  • FEI: 3008301917
Add To Cart